HBV-IN-8

• UNSPSC Description:

  HBV-IN-8 is a potent HBV inhibitor with an EC50 of 287.9 nM (WO2021213445A1, compound 13)[1].

• Target Antigen:

  HBV

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-anti-virus

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/hbv-in-8.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(NC1=CC(Cl)=C(F)C=C1)C(CC(C2=CN=C(N3CCC(CC(O)=O)CC3)S2)N4)N(C)S4(=O)=O

• Molecular Weight:

  546.04

• References & Citations:

  [1]Sultam derivatives and application thereof. WO2021213445A1.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2724224-57-9